Patricia Ann Duffy

Array ( [id] => 6870004 [patent_doc_number] => 20030082693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/127843 [patent_app_country] => US [patent_app_date] => 2002-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 63515 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082693.pdf [firstpage_image] =>[orig_patent_app_number] => 10127843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870006 [patent_doc_number] => 20030082695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/127846 [patent_app_country] => US [patent_app_date] => 2002-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 63515 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082695.pdf [firstpage_image] =>[orig_patent_app_number] => 10127846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664102 [patent_doc_number] => 20030203428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/127852 [patent_app_country] => US [patent_app_date] => 2002-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 63512 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203428.pdf [firstpage_image] =>[orig_patent_app_number] => 10127852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869997 [patent_doc_number] => 20030082686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/125926 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 55719 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082686.pdf [firstpage_image] =>[orig_patent_app_number] => 10125926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 401335 [patent_doc_number] => 07291700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-06 [patent_title] => 'PRO4985 polypeptide' [patent_app_type] => utility [patent_app_number] => 10/125930 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 550 [patent_figures_cnt] => 550 [patent_no_of_words] => 59080 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/291/07291700.pdf [firstpage_image] =>[orig_patent_app_number] => 10125930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792005 [patent_doc_number] => 20030087349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/125928 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 63515 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087349.pdf [firstpage_image] =>[orig_patent_app_number] => 10125928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792004 [patent_doc_number] => 20030087348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/125923 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 55717 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087348.pdf [firstpage_image] =>[orig_patent_app_number] => 10125923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846900 [patent_doc_number] => 20030166067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Islet cell antigen 1851' [patent_app_type] => new [patent_app_number] => 10/124089 [patent_app_country] => US [patent_app_date] => 2002-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20782 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166067.pdf [firstpage_image] =>[orig_patent_app_number] => 10124089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809113 [patent_doc_number] => 20030199052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/121052 [patent_app_country] => US [patent_app_date] => 2002-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 63514 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199052.pdf [firstpage_image] =>[orig_patent_app_number] => 10121052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468092 [patent_doc_number] => 20040120963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Compositions containing bacterium capable of converting lactic acid into butyric acid and method of preventing/treating hyperlactic acidemia in digestive tract and colon cancer by using the same' [patent_app_type] => new [patent_app_number] => 10/474000 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4379 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20040120963.pdf [firstpage_image] =>[orig_patent_app_number] => 10474000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779186 [patent_doc_number] => 20030050268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases' [patent_app_type] => new [patent_app_number] => 10/112653 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28161 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050268.pdf [firstpage_image] =>[orig_patent_app_number] => 10112653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5905050 [patent_doc_number] => 20020142002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Methods for protecting against lethal infection with bacillus anthracis' [patent_app_type] => new [patent_app_number] => 10/106014 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7643 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142002.pdf [firstpage_image] =>[orig_patent_app_number] => 10106014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6755332 [patent_doc_number] => 20030003109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Methods for protecting against lethal infection with bacillus anthracis' [patent_app_type] => new [patent_app_number] => 10/105694 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7647 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20030003109.pdf [firstpage_image] =>[orig_patent_app_number] => 10105694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6324057 [patent_doc_number] => 20020197272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Methods for protecting against lethal infection with bacillus anthracis' [patent_app_type] => new [patent_app_number] => 10/105695 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7644 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20020197272.pdf [firstpage_image] =>[orig_patent_app_number] => 10105695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6729661 [patent_doc_number] => 20030185851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Tet transactivator system' [patent_app_type] => new [patent_app_number] => 10/102143 [patent_app_country] => US [patent_app_date] => 2002-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8868 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185851.pdf [firstpage_image] =>[orig_patent_app_number] => 10102143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796420 [patent_doc_number] => 20030175294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Heterologous fusion protein constructs comprising a Leishmania antigen' [patent_app_type] => new [patent_app_number] => 10/098732 [patent_app_country] => US [patent_app_date] => 2002-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 33031 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175294.pdf [firstpage_image] =>[orig_patent_app_number] => 10098732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778190 [patent_doc_number] => 20030049271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Streptococcus pyogenes polypeptides and corresponding DNA fragments' [patent_app_type] => new [patent_app_number] => 10/078531 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10024 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049271.pdf [firstpage_image] =>[orig_patent_app_number] => 10078531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750386 [patent_doc_number] => 20030044906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Nucleic acids, proteins, and processes for producing proteins such as fusion proteins for the secretion of a protein of interest into bacterial supernatants' [patent_app_type] => new [patent_app_number] => 10/076634 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6710 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044906.pdf [firstpage_image] =>[orig_patent_app_number] => 10076634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142049 [patent_doc_number] => 07691804 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'BAFF receptor (BCMA), an immunoregulatory agent' [patent_app_type] => utility [patent_app_number] => 10/077137 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 30 [patent_no_of_words] => 12387 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691804.pdf [firstpage_image] =>[orig_patent_app_number] => 10077137 [rel_patent_id] =>[rel_patent_doc_number] =>)